Big Tech’s Big Day… And Second Half Energy Playbook 7/5/24
CNBC's "Fast Money"
00:00
Discussion on Harvard Study Linking Novo Nordisk Drugs to Rare Eye Disease
Exploring the study's findings linking Novo Nordisk's drugs to a rare eye disease in type 2 diabetes patients, alongside the stock rise and analysts' perspectives on the potential minimal impact.
Play episode from 21:41
Transcript
